Diana Roettger, PhD, and Olga Kubassova, PhD[email protected]MRIAdvanced imaging offers insight into targeted therapiesMajor breakthroughs are emerging in the development of targeted therapies that use the body's own immune system to attack cancer cells. But traditional methods of measuring the success of drug candidates are slow and expensive. Could advanced imaging help? Diana Roettger, PhD, and Olga Kubassova, PhD, of the Image Analysis Group offer a perspective.February 5, 2019Page 1 of 1Top StoriesClinical NewsLI-RADS CT/MRI liver malignancy features show high interreader agreementThe results could have implications for how LI-RADS CT/MRI (v2018) should be applied in clinical liver imaging practice.InterventionalGAE benefits may just be ‘placebo effect’MRIOpinion: Radiologists must be proactive to protect helium supplyEconomicsPodcast: Teleradiology leader discusses Indian radiology hub, AI initiativesSponsor ContentTurning Innovation into Everyday Efficiency
